Core Laboratories N.V.
CLB
NYSE
14.95
USD-0.19(-1.25%)
As of today
Core Laboratories N.V. fundamentals
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 487,267,000 | 470,252,000 | 489,735,000 | 509,790,000 | 523,848,000 | |
| Gross Profit | 102,125,000 | 83,840,000 | 78,919,000 | 94,049,000 | 88,373,000 | |
| Operating Income | -76,805,000 | 45,262,000 | 41,524,000 | 54,640,000 | 58,556,000 | |
| Net Income | -97,637,000 | 19,727,000 | 19,453,000 | 36,675,000 | 31,400,000 | |
| Total Assets | 568,579,000 | 580,853,000 | 578,354,000 | 586,395,000 | 590,406,000 | |
| Total Current Liabilities | 89,750,000 | 90,782,000 | 103,135,000 | 88,097,000 | 97,586,000 | |
| Total Equity | 75,573,000 | 161,001,000 | 188,954,000 | 229,807,000 | 257,736,000 | |
| Free Cash Flow | 45,988,000 | 23,040,000 | 14,740,000 | 14,210,000 | 43,360,000 | |
| Cash from Operations | 57,868,000 | 36,579,000 | 24,956,000 | 24,789,000 | 56,388,000 | |
| Cash from Investing | 7,851,000 | -10,223,000 | -3,856,000 | -6,652,000 | -6,394,000 | |
| Cash from Financing | -63,005,000 | -22,459,000 | -23,375,000 | -18,445,000 | -45,957,000 | |
| Net Change in Cash | 2,714,000 | 3,897,000 | -2,275,000 | -308,000 | 4,037,000 |